CKAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.282200E-01
Normal-vs-Stage2
8.246800E-01
Normal-vs-Stage3
1.112190E-01
Normal-vs-Stage4
9.616600E-01
Stage1-vs-Stage2
9.383400E-01
Stage1-vs-Stage3
2.049600E-01
Stage1-vs-Stage4
8.076200E-01
Stage2-vs-Stage3
1.014620E-01
Stage2-vs-Stage4
7.230000E-01
Stage3-vs-Stage4
2.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.299000E-01
Normal-vs-AfricanAmerican
6.899600E-01
Normal-vs-Asian
8.143000E-01
Caucasian-vs-AfricanAmerican
7.730600E-01
Caucasian-vs-Asian
9.989400E-01
AfricanAmerican-vs-Asian
7.738000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.631000E-01
Normal-vs-Female
8.878600E-01
Male-vs-Female
5.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.097000E-01
Normal-vs-Age(41-60Yrs)
9.601800E-01
Normal-vs-Age(61-80Yrs)
6.933200E-01
Normal-vs-Age(81-100Yrs)
9.654600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.969020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.905600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.237200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.305780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.446400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.048000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.267000E-01
Normal-vs-Daily Drinker
7.720800E-01
Normal-vs-Weekly Drinker
8.565200E-01
Normal-vs-Occasional Drinker
7.462400E-01
Normal-vs-Social Drinker
9.204600E-01
Non Drinker-vs-Daily Drinker
6.749400E-01
Non Drinker-vs-Weekly Drinker
5.493400E-01
Non Drinker-vs-Occasional Drinker
1.073360E-01
Non Drinker-vs-Social Drinker
4.092800E-01
Daily Drinker-vs-Weekly Drinker
8.273400E-01
Daily Drinker-vs-Occasional Drinker
2.426000E-01
Daily Drinker-vs-Social Drinker
6.776200E-01
Weekly Drinker-vs-Occasional Drinker
3.824800E-01
Weekly Drinker-vs-Social Drinker
8.599400E-01
Occasional Drinker-vs-Social Drinker
4.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.819200E-01
Normal-vs-Grade 2
9.576200E-01
Normal-vs-Grade 3
9.875200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.449200E-01
Grade 1-vs-Grade 3
1.730770E-01
Grade 1-vs-Grade 4
8.819200E-01
Grade 2-vs-Grade 3
6.028000E-01
Grade 2-vs-Grade 4
9.576200E-01
Grade 3-vs-Grade 4
9.875200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.588000E-01
Normal-vs-NonDiabetic
8.217200E-01
Diabetic-vs-NonDiabetic
3.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.176600E-01
Normal-vs-NoPancreatitis
8.061000E-01
Pancreatitis-vs-NoPancreatitis
9.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.000200E-01
Normal-vs-N1
7.987400E-01
N0-vs-N1
6.284800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.012200E-01
Normal-vs-TP53-NonMutant
8.815000E-01
TP53-Mutant-vs-TP53-NonMutant
3.381500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
